Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections

Completed · Phase 2

Conditions studied: Infection, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Antifungals such as voriconazole may be effective in controlling fungal infections. Combining voriconazole with interferon gamma may be more effective than voriconazole alone in treating fungal infections. PURPOSE: Randomized phase II trial to compare the effectiveness of voriconazole with or without interferon gamma in treating patients who have aspergillosis or other fungal infections.

Key facts

Study ID

NCT00059878

Run by

National Cancer Institute (NCI)

Starts

2003-08-01

Expected to finish

2005-01-01

Last updated by the study team

2013-06-19

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• Shands Cancer Center at the University of Florida Health Science Center — Gainesville, Florida, United States
• Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.